| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 09/06/2002 | WO2002068380A1 Synthetic excitatory amino acids |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/06/2002 | WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/04/2002 | EP1236711A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/04/2002 | EP1149066A4 Method of preparing alkylated salicylamides |
| 09/04/2002 | EP0883602B1 Lipids |
| 09/03/2002 | US6444820 Process for the manufacture of camptothecin derivatives |
| 09/03/2002 | US6444702 Central nervous system disorders |
| 09/03/2002 | US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 08/29/2002 | WO2002066420A2 Tryptase inhibitors |
| 08/29/2002 | WO2002066415A2 Non-steroidal modulators of estrogen receptors |
| 08/29/2002 | WO2002002520A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120140 Phosgene-free process for preparing carbamates |
| 08/29/2002 | US20020120136 Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives |
| 08/29/2002 | US20020120096 Capable of stably fixing a water-soluble polymer onto a surface structure by taking advantage of intermolecular interaction, thereby enabling the water-soluble polymer to be carried thereon without giving any damage |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020119979 Cancer therapy |
| 08/29/2002 | US20020119960 Drug resistance therapy |
| 08/29/2002 | US20020119910 Drug delivery |
| 08/29/2002 | CA2438711A1 Tryptase inhibitors |
| 08/28/2002 | EP1017734B1 Crosslinkable polyurea polymers |
| 08/28/2002 | CN1365969A Process for preparing aminoformate |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089761C Sidechain-bearing texanes and its preparing process |
| 08/27/2002 | US6441044 Cycloalkyl carboxylic acid amides, their production and their use as fungicides in agriculture |
| 08/27/2002 | US6441035 Administering to a mammal for the treatment of dry eye or other disorders requiring the wetting of the eye a heteroatom such as nitrogen, oxygen or sulfur interrupted hydroxyeicosatetraenoic acid related compounds |
| 08/27/2002 | CA1341386C Acid-labile anchor groups for the synthesis of peptide amides by a solid-phase method |
| 08/22/2002 | WO2002064561A1 $g(d)1-pyrrolines used in pest control |
| 08/22/2002 | WO2002064549A1 Ppar agonists |
| 08/22/2002 | WO2002064130A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/22/2002 | US20020115743 Dental materials with extendable work time, kits, and methods |
| 08/22/2002 | US20020115721 Alkyl carboxy amino acid analogs of glutamic acid; treating neurological, neuropsychological, neuropsychiatric, neurodegenerative, neuropsychopharmacological and functional disorders; postsynaptic glutamate receptor |
| 08/22/2002 | US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance |
| 08/22/2002 | CA2438551A1 Ppar agonists |
| 08/22/2002 | CA2438492A1 Proliferative activator receptor (ppar) compounds |
| 08/21/2002 | EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 08/20/2002 | US6437150 Compounds having protected hydroxy groups |
| 08/20/2002 | US6437032 Compound bearing an urethane linkage, which is an addict of ricinoleic esters and an isocynate, useful as a plasticizer for polyvinyl chloride (PVC) and a process for preparing such compound |
| 08/20/2002 | US6436994 Administering a patient an effective amount of hydroxyeicosatetraenoic acid related compounds to treat the dry eye |
| 08/20/2002 | US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders |
| 08/15/2002 | WO2002062815A1 Hybrid protecting groups |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | US20020111347 Nervous system disorders |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/14/2002 | EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
| 08/14/2002 | EP0956281B1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | DE10106455A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/13/2002 | US6433017 Amphiphilic polyamine compounds |
| 08/13/2002 | US6432933 Malaria therapy; alzheimer's disorders |
| 08/08/2002 | WO2002060862A1 Methods of chemical synthesis of phenolic nitrogen mustard prodrugs |
| 08/08/2002 | WO2002060340A2 Method for identifying maxi-k channel blockers |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | US20020107266 Amides used particularly in the treatment, prevention or amelioration of one or more symptoms of malaria or Chagas' disease; inhibiting the activity of falcipain or cruzain |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | DE10105077A1 Hybrid-Schutzgruppe Hybrid-protecting group |
| 08/08/2002 | CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells |
| 08/07/2002 | EP1229033A2 2-Fluoro-(oxid-thiopyran-4-yl)benzene derivatives |
| 08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1227809A2 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP0829473B1 Processes for preparing cyclic compounds |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362640A Silver-halides photo-sensitive emulsion layer with reinforced photographic photosensibility |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/01/2002 | WO2002059077A1 Aminoethanol derivatives |
| 08/01/2002 | WO2002059074A1 Benzylamine analogue |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | US20020103401 Includes a step in which ortho-nitrotoluene is reacted with one or more acrylic acid derivatives such as acrylonitrile |
| 08/01/2002 | US20020103398 Double bond acts as a rigidifying element, for unexpected potency and selectivity for inhibition of inducible nitric oxide synthase over the constitutive isoforms |
| 08/01/2002 | US20020103387 Compounds which mimic the chemical and biological properties of discodermolide |
| 08/01/2002 | US20020103319 Water-soluble carbamate materials |
| 08/01/2002 | US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 08/01/2002 | US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 08/01/2002 | CA2435883A1 Benzylamine analogue |
| 07/31/2002 | EP1227095A2 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 07/31/2002 | EP0799059B1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 07/31/2002 | CN1361098A Prepn of chiral compound L-homophenprobamate and its salt |
| 07/25/2002 | WO2002056827A2 Substituted felbamate derived compounds |
| 07/25/2002 | WO2002056681A2 Novel intermediates and process to pyrimidinedione herbicides |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099092 For therapy of neurological conditions, e.g. epilepsy and pain |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | CA2427058A1 Substituted felbamate derived compounds |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/23/2002 | US6423869 Polyol-amino acid compounds having anti-helicobacter pylori activity |